Sea snake Hydrophis cyanocinctus venom. I. Purification, characterization and N-terminal sequence of two phospholipases A2

Toxicon

Volumn 37, Issue 11, 1999, Pages 1505-1520

  Ali, Syed Abid ^a,b   Alam, Junaid M ^c   Stoeva, Stanka ^b   Schütz, J ürgen ^b   Abbasi, Atiya ^a   Zaidi, Zafar H ^a   Voelter, Wolfgang ^b  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c CIVIL HOSPITAL   (Pakistan)

Author keywords

Disintegrins; Hydrophiinae; Hydrophis cyanocinctus; Phospholipase A2; Platelet aggregation inhibitor; RGD sequence; Sea snake; Sequence homology; Toxins; Venom

Indexed keywords

ANTITHROMBOCYTIC AGENT; DISINTEGRIN; PHOSPHOLIPASE A2; SNAKE VENOM;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME PURIFICATION; LD 50; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE HOMOLOGY; THERMOSTABILITY; TOXIN ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; EDEMA; FEMALE; HEMOLYSIS; HYDROPHID VENOMS; ISOENZYMES; LETHAL DOSE 50; MALE; MASS SPECTROMETRY; MICE; MOLECULAR SEQUENCE DATA; PHOSPHOLIPASES A; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ELAPIDAE; HYDROPHIINAE; HYDROPHIS CYANOCINCTUS; SERPENTES;

EID: 0033231650     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(99)00091-4     Document Type: Article

References (62)

1. Acott C., Williamson J. Sea snake. Williamson J.A., Fenner P.J., Burnett J.W., Rifkin J.F. Venomous and Poisonous Marine Animals: a Medical and Biological Handbook. 1996;396-402 UNSW Press, Sydney.
2. 2: a structural review. Toxicon. 34:1996;827-841.
3. 2 at 2.5 Å J. Biol. Chem. 260:1985;9742-9745.
4. 2. Toxicon. 36:1998;75-92.
5. 2 from the venom of the Taiwan habu Trimeresurus mucrosquamatus. Biotechnol. Appl. Biochem. 19:1994;61-73.
6. 2 from Hemachatus hemachatus and Naja naja atra venoms. Toxicon. 19:1981;61-71.
7. 2: effects on enzymatic activity, lethality and some pharmacological properties. Toxicon. 21:1983;209-218.
8. 2 from snake venom to human secreted forms. J. Mol. Evol. 31:1990;228-238.
9. 2 from cobra venom (Naja naja naja). Lowenstein J.M. Methods in Enzymology. vol. 71:1981;703-710 Academic Press, New York.
10. 2. J. Biol. Chem. 269:1994;13057-13060.
11. Dennis M.S., Henzel W.J., Pitti R.M., Lipari M.T., Napier M.A., Deisher T.A., Bunting S., Lazarus R.A. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. Proc. Natl. Acad. Sci. USA. 87:1989;2471-2475.
12. 2 from Bothrops godmani (Godman's pit viper) snake venom. Arch. Biochem. Biophys. 298:1992;135-142.
13. 2 from sea snake Aipysurus laevis. Nucleic Acid Res. 16:1988;9048.
14. 2, secondary-structure prediction, circular dichroism and relative interface hydrophobicity. Eur. J. Biochem. 137:1983;537-544.
15. 2 according to sequence, evolutionary and pharmacological implications. Eur. J. Biochem. 137:1983;545-551.
16. 2 from elapid snake venoms. Toxic. Appl. Pharmac. 59:1981;375-381.
17. Freedmann J.E., Snyder S.H. Vipoxin, a protein from Russells viper venom with high affinity for biogenic amine receptors. J. Biol. Chem. 256:1981;13172-13179.
18. 2 from Indian cobra reveals a trimeric association. Proc. Natl. Acad. Sci. USA. 90:1993;342-346.
19. 2 from the venom of Agkistrodon piscivorus piscivorous. J. Biol. Chem. 272:1997;3573-3582.
20. Harris J.B. Phospholipases in snake venoms and their effects on nerve and muscle. Harvey A.L. Snake Toxins. 1991;91-129 Pergamon Press, New York.
21. 2. Dennis E.A. Methods in Enzymology. vol. 197:1991;201-214 Academic Press, New York.
22. 2 of Vipera russelli venom. Toxicon. 22:1984;359.
23. 2 purified from Ophiophagus hannah (king cobra) venom on rat heart. Toxicon. 31:1993;627-635.
24. 2 from the venom of Ophiophagus hannah (king cobra): a novel cobra venom enzyme with `pancreatic loop'. Arch. Biochem. Biophys. 338:1997;150-156.
25. Huang T.F., Yeh H.I., Ouyang C. Mechanism of action of the platelet aggregation inhibitor purified from Agkistrodon halys (mamushi) snake venom. Toxicon. 22:1984;243-251.
26. 2 and their zymogens: unusual conformations simulating helix content. Biochem. Biophys. Acta. 494:1977;285-292.
27. Kini R.M., Iwanga S. Structure-function relationships of phospholipases. I. Prediction of presynaptic neurotoxicity. Toxicon. 24:1986;527-541.
28. Kini R.M., Iwanga S. Structure-function relationships of phospholipases. II. Charge density distribution and the myotoxicity of presynaptically neurotoxic phospholipases. Toxicon. 24:1986;895-905.
29. 2. J. Biol. Chem. 262:1987;14402-14407.
30. 2 isoenzymes from Naja nigricollis venom. Thromb. Haemost. 60:1988;170-173.
31. 2. Toxicon. 27:1989;613-635.
32. Kini R.M., Evans H.J. Effects of snake venom proteins on blood platelets. Toxicon. 28:1990;1387-1422.
33. 2 from Vipera a. zinnikeri venom. Arch. Biochem. Biophys. 327:1996;303-307.
34. Kondo H., Kondo S., Ikezawa H., Murata R., Ohsaka A. Studies on the quantitative method for determination of haemorrhage activity of habu snake venom. Jpn. J. Sci. Biol. 13:1960;43-51.
35. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
36. 2 from crotalid venoms. Toxicon. 24:1986;161-168.
37. Ouyang C., Teng C.M., Huang T.F. Characterization of snake venom principles affecting blood coagulation and platelet aggregation. Asia Pac. J. Pharm. 2:1987;169-179.
38. 2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper). Biochem. J. 319:1996;961-968.
39. Perbandt M., Wilson J.C., Eschenburg S., Mancheva I., Aleksiev B., Genov N., Willingmann P., Weber W., Singh T.P., Betzel Ch. Crystal structure of vipoxin at 2.0 Å: an example of regulation of a toxic function generated by molecular evolution. FEBS Lett. 412:1997;573-577.
40. 2 by modification of carboxylate groups. Biochem. Pharmacol. 32:1983;3525-3530.
41. Rosenberg P. The relationship between enzymatic activity and pharmacological properties of phospholipases in natural poisons. Harris J.B. Natural Toxins. 1986;129-174 Oxford University Press, Oxford.
42. Rosenberg P., Ghassemi A., Condrea E., Dhillon D., Yang C.C. Do chemical modifications dissociate between the enzymatic and pharmacological activities of β-bungarotoxin and notexin? Toxicon. 27:1989;137-159.
43. 2. Schumaker V.N. Advances in Protein Chemistry. vol. 45:1994;53-88 Academic Press, New York.
44. 2+ reveal trimeric packing. J. Mol. Biol. 279:1998;223-232.
45. Stocker K.F. Composition of snake venoms. Stocker K.F. Medical Use of Snake Venom Proteins. 1990;33-56 CRC Press, Boca Raton, FL.
46. 2 enzymes. Biochem. Int. 19:1989;803-810.
47. Tan N.-H., Ponnudurai G. A comparative study of the biological properties of some sea snake venoms. Comp. Biochem. Phsiol. 99B:1991;351-354.
48. Teng C.-M., Chen Y.-H., Ouyang C. Biphasic effect on platelet aggregation by phospholipase A purified from Vipera russellii snake venom. Biochem. Biophys. Acta. 772:1984;393-402.
49. 2 on platelet aggregation in comparison with those produced by arachidonic acid and lysophosphatidylcholine. Thromb. Res. 44:1986;875-886.
50. 2 complexed with a substrate-derived inhititor. Nature (London). 347:1990;689-691.
51. 2 from the venom of Taiwan habu Trimeresurus mucrosquamatus. Biochem. J. 311:1995;895-900.
52. Tu A.T. Biotoxicology of sea snake venoms. Annal. Emerg. Med. 16:1987;149-154.
53. 2. EMBO J. 14:1995;4123-4131.
54. 2 from Vipera russelli venom and its interaction aristolochic acid. Toxicon. 23:1985;617-623.
55. 2 enzymes from habu (Trimeresurus Flavoviridis) venom and their interaction with the alkaloid aristolochic acid. Toxicon. 25:1987;501-515.
56. 2 from Vipera russelli (Russells viper) snake venom. Toxicon. 26:1988;713-720.
57. 2 from the venom of Agkistrodon halys Pallas at 2.0 Å resolution. J. Mol. Biol. 255:1996;669-676.
58. Williams J., Rucinski B., Holt J., Niewiarowski S. Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor. Biochim. Biophys. Acta. 1039:1990;81-89.
59. Yamakawa M., Nozaki M., Hokama Z., Hayashi K., Sawai Y. Fractionation of sakishmna-habu (Trimeresurus elegans) venom and lethal haemorrhagic and edema forming activity of the fractions. Ohsaka A. Animal, Plant and Microbial Toxins. vol. I:1976;97-103 Plenum Press, New York.
60. Yang T.Y., Lee C.Y. Pharmacological studies on the venom of a sea snake Hydrophis cyanocinctus. Rosenberg P. Toxins, Animals, Plant and Microbial. 1978;261-292 Pergamon Press, New York.
61. 2 from Agkistrodon halys Pallas. Acta Biochem. Biophys. Sinica. 27:1995;361-366.
62. 2 from Agkistrodon halys Pallas at 2.13 Å resolution. Acta Cryst. D. 54:1998;510-521.